I agree that a new company name befitting the new identity is a good thing.
But is anyone concerned that it is too close to the name of an existing ASX company - Neurizer:NRZ. And also Neuren:NEU.
As @kpax pointed out, Neurizon Therapeutics is already known as a part of a Swiss company - Neurizon Pharma.
I believe the new company name should be a unique identifier not to be confused with any other organisation.
We already own Pitney Pharmaceuticals. How about we name the new company Pitney NeuroTherapeutics?
I know it sounds rather bland, but it is simple, easily spelled and pronounced, and synthesises the two arms of the company.
Any thoughts?
I agree that a new company name befitting the new identity is a...
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $92.46M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.0¢ | $118.1K | 605.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 271759 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 84950 | 5 |
View Market Depth
| Last trade - 15.35pm 08/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |